| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.19 | 7e-05 |